Moderna Inc (MRNA)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 10,901,000 | 13,854,000 | 19,123,000 | 14,145,000 | 2,561,000 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $10,901,000K)
= 0.00
Based on the data provided, Moderna Inc has maintained a consistent debt-to-capital ratio of 0.00 from December 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has no debt relative to its total capital, implying that Moderna is primarily financed through equity rather than debt. This can be seen as a positive indicator of financial health and stability for the company, as it suggests a lower financial risk and less reliance on external borrowing to fund its operations and growth initiatives. Additionally, a low or zero debt-to-capital ratio can also indicate strong investor confidence and creditworthiness.
Peer comparison
Dec 31, 2024